18FDG-microPET and MR DTI findings in Tor1a+/- heterozygous knock-out mice

Neurobiol Dis. 2015 Jan:73:399-406. doi: 10.1016/j.nbd.2014.10.020. Epub 2014 Nov 4.

Abstract

TorsinA is an important protein in brain development, and plays a role in the regulation of neurite outgrowth and synaptic function. Patients with the most common form of genetic dystonia carry a mutation (DYT1) in one copy of the Tor1a gene, a 3-bp deletion, causing removal of a single glutamic acid from torsinA. Previous imaging studies have shown that abnormal cerebellar metabolism and damaged cerebello-thalamo-cortical pathway contribute to the pathophysiology of DYT1 dystonia. However, how a mutation in one copy of the Tor1a gene causes these abnormalities is not known. We studied Tor1a heterozygous knock-out mice in vivo with FDG-PET and ex vivo with diffusion tensor imaging. We found metabolic abnormalities in cerebellum, caudate-putamen, globus pallidus, sensorimotor cortex and subthalamic nucleus. We also found that FA was increased in caudate-putamen, sensorimotor cortex and brainstem. We compared our findings with a previous imaging study of the Tor1a knock-in mice. Our study suggested that having only one normal copy of Tor1a gene may be responsible for the metabolic abnormalities observed; having a copy of mutant Tor1a, on the other hand, may be responsible for white matter pathway damages seen in DYT1 dystonia subjects.

Keywords: DTI; Dystonia; Glucose metabolism; Heterozygous knock-out mice; Tor1a; TorsinA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diffusion Tensor Imaging / methods*
  • Dystonia / metabolism*
  • Dystonia / pathology
  • Fluorodeoxyglucose F18
  • Gray Matter / metabolism*
  • Gray Matter / pathology
  • Male
  • Mice
  • Mice, Knockout
  • Molecular Chaperones / metabolism*
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • White Matter / metabolism*
  • White Matter / pathology

Substances

  • Dyt1 protein, mouse
  • Molecular Chaperones
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18